Stockscreener 앱 받기
0.67
2.19%
-0.015
시간 외 거래:
.67
전일 마감가:
$0.685
열려 있는:
$0.713
하루 거래량:
544.19K
Relative Volume:
0.69
시가총액:
$31.60M
수익:
-
순이익/손실:
$-35.58M
주가수익비율:
-0.2528
EPS:
-2.65
순현금흐름:
$-42.82M
1주 성능:
-5.57%
1개월 성능:
-1.00%
6개월 성능:
-45.53%
1년 성능:
-38.53%
1일 변동 폭
$0.668
$0.7149
1주일 범위
$0.668
$0.81
52주 변동 폭
$0.6108
$3.02
Iterum Therapeutics Plc Stock (ITRM) Company Profile
명칭
Iterum Therapeutics Plc
전화
(872) 225-6077
주소
3 DUBLIN LANDINGS, DUBLIN 1
ITRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.67 | 30.59M | 0 | -35.58M | -42.82M | -2.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-28 | 업그레이드 | Gabelli & Co | Sell → Hold |
| 2021-03-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | 다운그레이드 | Gabelli & Co | Buy → Sell |
| 2019-12-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | 개시 | H.C. Wainwright | Buy |
모두보기
Iterum Therapeutics Plc 주식(ITRM)의 최신 뉴스
Multi factor analysis applied to Iterum Therapeutics plcJuly 2025 Decliners & Verified Short-Term Plans - newser.com
Technical signs of recovery in Iterum Therapeutics plcWeekly Trade Report & Safe Capital Growth Plans - newser.com
Can Iterum Therapeutics plc stock deliver sustainable ROETreasury Yields & Daily Market Momentum Tracking - newser.com
Is Iterum Therapeutics plc stock a dividend growth opportunityRate Hike & Low Risk Investment Opportunities - newser.com
Full technical analysis of Iterum Therapeutics plc stockJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Why Iterum Therapeutics plc stock is favored by pension funds2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Volatility clustering patterns for Iterum Therapeutics plcJobs Report & Accurate Technical Buy Alerts - newser.com
Iterum Therapeutics plc stock trendline breakdownWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com
Wall Street Zen Upgrades Iterum Therapeutics (NASDAQ:ITRM) to Hold - Defense World
How Iterum Therapeutics plc stock trades before earningsInflation Watch & Low Volatility Stock Recommendations - newser.com
How to interpret RSI for Iterum Therapeutics plc stockWeekly Stock Analysis & Weekly Top Gainers Trade List - newser.com
Is it time to cut losses on Iterum Therapeutics plcBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Valuation Update: Is Iterum Therapeutics plc stock risky to hold nowInflation Watch & Stepwise Trade Execution Plans - خودرو بانک
Iterum Therapeutics sees cash runway into 2026 - Yahoo Finance
Is Iterum Therapeutics plc forming a reversal patternGDP Growth & Technical Entry and Exit Alerts - newser.com
Merger Talk: How is Iterum Therapeutics plc managing supply chain issuesJuly 2025 Closing Moves & Safe Capital Growth Plans - خودرو بانک
Iterum Therapeutics launches antibiotic ORLYNVAH in targeted U.S. markets By Investing.com - Investing.com Australia
What MACD signals say about Iterum Therapeutics plc2025 Biggest Moves & AI Driven Stock Reports - newser.com
Iterum Therapeutics (ITRM) Advances Launch and Patent Innovations - GuruFocus
Iterum Therapeutics launches antibiotic ORLYNVAH in targeted U.S. markets - Investing.com
Iterum Therapeutics Provides Business Update and Launches ORLYNVAH™ to Combat Multi-Drug Resistant Infections - Quiver Quantitative
New Antibiotic ORLYNVAH Launches in US: Iterum Therapeutics Targets Multi-Drug Resistant Infections - Stock Titan
Using data tools to time your Iterum Therapeutics plc exit2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Aug Volume: Is Iterum Therapeutics plc part of any major indexMarket Movement Recap & Daily Profit Maximizing Tips - خودرو بانک
Applying Elliott Wave Theory to Iterum Therapeutics plcQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Can technical indicators confirm Iterum Therapeutics plc’s reversalJuly 2025 Levels & Low Risk Entry Point Guides - newser.com
Evaluating Iterum Therapeutics plc with trendline analysis2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Iterum Therapeutics Faces Shareholder Pushback on Key Proposals - MSN
Iterum Therapeutics Plc (ITRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):